US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
Inventiva (6IV) 銘柄情報

Inventiva (6IV)

3.05

0.005

(0.16%)

終了 6月21日 5:00AM

Inventiva (6IV) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

3.05

( 0.16% )

買値

3.02

売値

3.075

出来高

558

3.015 日の範囲 3.04

2.595 52 週間の範囲 6.16

時価総額

前日終値

3.045

始値

3.015

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

350,036 €

発行済株式数

207,707,475

配当利回り

PER

-1.8

1 株当たり利益 (EPS)

-1.9

歳入

6.76M

純利益

-354.14M

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome prolifer... Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

inventivapharma.com

本社

Daix, France

設立

2026

Inventiva is listed in the Healthcare sector of the Tradegate (DE) with ticker 6IV. The last closing price for Inventiva was 3.05 €. Over the last year, Inventiva shares have traded in a share price range of 2.595 € to 6.16 €.

Inventiva currently has 207,707,475 shares in issue. The market capitalisation of Inventiva is 633.51 € million. Inventiva has a price to earnings ratio (PE ratio) of -1.80.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.35	-10.2941176471	3.4	3.515	3.015	4415	3.21317902	DE
4	-1.46	-32.3725055432	4.51	4.7249999	3.015	2628	3.54354213	DE
12	-1.93	-38.7550200803	4.98	5.0599999	3.015	1731	4.00191569	DE
26	-0.6	-16.4383561644	3.65	6.16	3.015	2442	4.66275747	DE
52	0.305	11.1111111111	2.745	6.16	2.595	3085	4.14120283	DE
156	-0.215	-6.58499234303	3.265	6.16	1.452	1950	3.68834025	DE
260	-0.215	-6.58499234303	3.265	6.16	1.452	1950	3.68834025	DE

6IV - Frequently Asked Questions (FAQ)

What is the current Inventiva share price?

The current share price of Inventiva is 3.05 €

How many Inventiva shares are in issue?

Inventiva has 207,707,475 shares in issue

What is the market cap of Inventiva?

The market capitalisation of Inventiva is EUR 633.51M

What is the 1 year trading range for Inventiva share price?

Inventiva has traded in the range of 2.595 € to 6.16 € during the past year

What is the PE ratio of Inventiva?

The price to earnings ratio of Inventiva is -1.8

What is the cash to sales ratio of Inventiva?

The cash to sales ratio of Inventiva is 105.07

What is the registered address of Inventiva?

The registered address for Inventiva is 50 rue de Dijon, Daix, Burgundy, 21121

What is the Inventiva website address?

The website address for Inventiva is inventivapharma.com

Which industry sector does Inventiva operate in?

Inventiva operates in the Biotechnology & Life Sciences sector

fuagf

Yep. On Henley though, as thought could be;

Russell Henley is widely regarded as one of the best wind and adverse-condition players on the PGA Tour.

https://www.google.com/search?q=pga+stats+-+how+is+henley+in+the+wind+&client=firefox-b-d&hs=rwRV&sca_esv=77e9a8666bf485

Seminole Red

Seminole Red 11分前

I guess if you look back on history the US Open has always been a tough venue wherever its played

DocLee

DocLee 30分前

Hi, Dedugan. I share the frustration that you and many (?most?) others feel at the extended wait that we are all are experiencing for the MAA to be approved.

However, I don't think that your concern - "why can't MHRA approve it for use at the patient's and physician's discretion and

Wayne R

Wayne R 38分前

Yup, the new reality isn't buying or selling based on fundamentals, it's, baah, why not. Follow the sheep 🐑

sony12

sony12 39分前

Is Klug in jail ?

DoF

Or maybe to spend more time on his other pusuits, like
Digialage Inc (Peter Michaels, President)
SocialSafe Inc (Peter Michaels, President and Director, Neal Newgard & Awan D Nord, Directors)
ThaHOUSE Inc (Ian Caloun, President, Peter Michaels, Director)

Ammarmalhas

Ammarmalhas 55分前

Sleven,
I have been reading the back and forth exchange between you guys and I can only say it is a very healthy and important exercise that enriches this ongoing discussion and the whole forum.
Please do not stop posting and please continue your well appreciated intervention in the di

Mr.anderson1

Mr.anderson1 59分前

MEHA's Defense Strategy Before the PanelTo avoid permanent delisting, MEHA's legal and executive teams must present a definitive plan to the Panel demonstrating how they will quickly lift the share price back over the $1.00 threshold. Their primary arguments will rely on two primary elements: [https

G-star 1時間前

The BOD per co-founder ZUBCEVIK has stated Mayer is no longer with the company. Eric Nelson, PhD has been appointed CEO.

So according to your post, Ken Mayer was CEO on June 17th.
According to another,he was already gone and replaced. That’s not a ‘positive development’ ,that’s

fuagf

fuagf 1時間前

Looks like it, but how many do. Guessing he is like most everyone, rather have calm, and that +10 was a real exception, in that he just had a terrible day because we were counting on him doing his more usual thing. Chuckle, ignore the last 11 words there.

Genz2

Genz2 1時間前

It’s hard to believe that the CEO of Crowdstrike, George Kurtz’s net worth is more than Satya Nadella, CEO of Microsoft!!! Especially when Wave and Microsoft’s cybersecurity is so much better than Crowdstrike’s!!!!

FanOfspringsteen

FanOfspringsteen 1時間前

Just give me $1.50

Just give me $1.50 1時間前

Literally everyone is dying waiting on Rat.

2 confirmed deaths on iHub and 1 on Elite's very own Board of Directors.

https://elite.irpass.com/profiles/investor/ResLibraryView.asp?ResLibraryID=87957&GoTopage=2&Category=2163&BzID=2258&t=2180&G=939

I'm expec

Seminole Red

Seminole Red 1時間前

henley must not like the wind....

Just give me $1.50

Just give me $1.50 2時間前

I'm also submitting 10 questions, but only in two categories as seen below:

Mikah Scam
1. Confidential
2. Confidential
3. Confidential
4. Confidential
5. Confidential

Rat's Resignation
1. Confidential
2.

Just give me $1.50

Just give me $1.50 2時間前

You act like it's not Rat's fault that we're not on the Nasdaq.

Like he has zero control of where Elite trades and we're stuck on the otc.

Lol.

Case closed -- Rat is a complete and utter FAILURE

Institutions can’t invest in penny stocks, by

The_Pro

The_Pro 2時間前

As of June 17th Ken Mayer is CEO of Electrome.io.

This per news PR dated June 17th, 2026.

Excerpt "This is an exciting moment for both organizations,” said Ken Mayer, CEO of Electrome Corporation. This was in the PR.

https://www.theglobeandmail.com/inve

skitahoe

skitahoe 2時間前

Much of today's discussions centered around the production of DCVax-L, I believe that I've been saying how important the EDEN is for something in excess of a year. I also believe that the delay in the construction of the cleanroom is timed to when the EDEN is anticipated to be ready. I don't know

Walker429

Walker429 2時間前

100 million galaxies, with 100 billion planets, and some how we end up here with IH Admin Shelly who is double vaxxed and triple boosted with six pronouns. Lord have mercy!

FOFreddie

FOFreddie 2時間前

The NWS was illegal but the warrants have always been legal and a valid contractual right of the UST. Two different issues

G-star 2時間前

Founder gone before commercial launch equals “good news”?
That’s an impressive level of optimism. Markets usually call that a red flag until proven otherwise.
“’Nuff said” doesn’t replace facts.

G-star 2時間前

Nothing says “great news” quite like the founder walking away before commercial operations even begin.

But sure, let’s call it a “strategic upgrade” and hope the market agrees.
Reality will eventually separate genuine progress from promotional spin.

1kgwxman

1kgwxman 3時間前

Oh really? 😄 That's not what my sources told me.
I asked two of my fellow high school classmates, who taught math and physics at the university level, and retired now, about this conference.
Both said it is a big deal.
They know of Brandenburg's 40 years of work, trying

flipper44

flipper44 3時間前

Just watched Pressure. Doctor Bosch, (immunologist), Dr. Liau and Professor Ashkan (brain surgeons) remind me a bit of Doctor Stagg (meteorologist). They don’t throw the baby out with the bath water. They look at existing scientific data, and when that data was incomplete, they identified the g

Future Capital Holding AD

Global X Management AUS

DJ Commodity Index Energ...

International bond 0.875...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。